These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34536162)

  • 21. Role of salivary epidermal growth factor in the pathogenesis of Barrett's columnar lined oesophagus.
    Gray MR; Donnelly RJ; Kingsnorth AN
    Br J Surg; 1991 Dec; 78(12):1461-6. PubMed ID: 1773326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased rate of salivary epidermal growth factor secretion in patients with juvenile periodontitis.
    Hormia M; Thesleff I; Perheentupa J; Pesonen K; Saxén L
    Scand J Dent Res; 1993 Jun; 101(3):138-44. PubMed ID: 8322007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary function in patients with reflux esophagitis: effect of cisapride.
    Chen SD; Kao CH; Chang CS; Chen GH
    J Nucl Med; 1998 Aug; 39(8):1449-52. PubMed ID: 9708526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary egf concentration in adults with reflux chronic laryngitis before and after treatment: preliminary results.
    Eckley CA; Rios Lda S; Rizzo LV
    Braz J Otorhinolaryngol; 2007; 73(2):156-60. PubMed ID: 17589721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
    Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
    J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The secretory characteristics of epidermal growth factor in human saliva.
    McGurk M; Hanford L; Justice S; Metcalfe RA
    Arch Oral Biol; 1990; 35(8):653-9. PubMed ID: 2256820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of salivary and nasal lavage pepsin with MII-pH testing.
    Klimara MJ; Johnston N; Samuels TL; Visotcky AM; Poetker DM; Loehrl TA; Blumin JH; Bock JM
    Laryngoscope; 2020 Apr; 130(4):961-966. PubMed ID: 31329290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of epidermal growth factor and Na+/H+ exchanger-1 in esophageal epithelial defense against acid-induced injury.
    Fujiwara Y; Higuchi K; Takashima T; Hamaguchi M; Hayakawa T; Tominaga K; Watanabe T; Oshitani N; Shimada Y; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G665-73. PubMed ID: 16306134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of smoking cessation on salivary function in healthy volunteers.
    Trudgill NJ; Smith LF; Kershaw J; Riley SA
    Scand J Gastroenterol; 1998 Jun; 33(6):568-71. PubMed ID: 9669624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the healing of the esophageal mucosa improve the function of the esophageal submucosal and salivary glands?
    Sarosiek J
    Ann N Y Acad Sci; 2016 Sep; 1380(1):155-161. PubMed ID: 27532891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary epidermal growth factor in patients with and without acid peptic disease.
    Maccini DM; Veit BC
    Am J Gastroenterol; 1990 Sep; 85(9):1102-4. PubMed ID: 2389722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
    Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
    Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The modified glucose clearance test: a novel non-invasive method for differentiating non-erosive reflux disease and erosive oesophagitis.
    Fujinami H; Kudo T; Miyazaki T; Hosokawa A; Mihara H; Ando T; Sugiyama T
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1259-64. PubMed ID: 18761705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis.
    Helm JF; Dodds WJ; Hogan WJ
    Gastroenterology; 1987 Dec; 93(6):1393-7. PubMed ID: 3678754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor in saliva and gastric juice: response to histamine.
    Tunio AM; Hobsley M
    Gut; 1995 Sep; 37(3):335-9. PubMed ID: 7590427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The parotid gland is the main source of human salivary epidermal growth factor.
    Thesleff I; Viinikka L; Saxén L; Lehtonen E; Perheentupa J
    Life Sci; 1988; 43(1):13-8. PubMed ID: 3290608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary parameters and teeth erosions in patients with gastroesophageal reflux disease.
    Corrêa MC; Lerco MM; Cunha Mde L; Henry MA
    Arq Gastroenterol; 2012; 49(3):214-8. PubMed ID: 23011245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of proton pump inhibitor-resistant severe reflux esophagitis and efficacy of vonoprazan in elderly (older than 75 years) and non-elderly groups.
    Hoshino S; Momma E; Motomiya R; Tanabe T; Koeda M; Hoshikawa Y; Kawami N; Iwakiri K
    JGH Open; 2024 Jan; 8(1):e13023. PubMed ID: 38268954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diminished salivary epidermal growth factor secretion: a link between Sjögren's syndrome and autoimmune gastritis?
    Koskenpato K; Ainola M; Przybyla B; Kouri VP; Virkki L; Koskenpato J; Ristimäki A; Konttinen YT
    Scand J Rheumatol; 2016; 45(2):118-21. PubMed ID: 26399281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of EGF and VEGF in patients with primary and secondary Sjögren's syndrome.
    Błochowiak KJ; Trzybulska D; Olewicz-Gawlik A; Sikora JJ; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
    Adv Clin Exp Med; 2018 Apr; 27(4):455-461. PubMed ID: 29558032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.